The following is a summary of “Immunological sub-phenotypes and response to convalescent plasma in COVID-19 induced ARDS: a ...
The ASUNCTIS trial evaluated asunercept's safety and efficacy in COVID-19, showing trends toward faster recovery despite not ...
The full indication for vilobelimab is as a treatment for adult patients with SARS‑CoV-2‑induced ARDS who are receiving ...